New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

What just happened? Qualcomm has emerged victorious in a high-stakes trial against Arm Holdings over a disputed chip technology license. The case, which unfolded in federal court in Delaware ...

MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of ...

The trial stemmed from Qualcomm’s $1.4 billion purchase of Nuvia, a startup specializing in chip designs based on Arm’s architecture.Arm contended that Qualcomm’s use of Nuvia’s technology ...

Another ARVIS rTSA today. “Fit score” is how accurately the bone landmark registration matches the preop plan. Case review shows exactly where the final implant ended up, including final ...

For example, a 5/1 ARM will have the same rate for the first five years, then can adjust each year after that—meaning the rate might go up or down, based on the market. An ARM isn’t for everyone.

Michigan boasts two updated National Historic Landmarks — both nestled in the state's far northwest in the Keweenaw Peninsula. The recent update to the Calumet Historic District and Quincy ...

We expect Arm will keep gaining market share in the data center from x86 architecture, as its chips consume less power and data centers need to minimize energy consumption. We also expect share ...